Hepatology(Liver, Pancreatic, Gall Bladder)

  • Home
  • Hepatology(Liver, Pancreatic, Gall Bladder)
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Conditions:   Non-Alcoholic Steatohepatitis;   Non-Alcoholic Fatty Liver Disease
Intervention:   Drug: Semaglutide
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 23, 2019 / by / in
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Conditions:   Colon Cancer;   Pancreatic Cancer;   Cholangiocarcinoma;   Mestatic Colon Carcinoma;   Liver Metastasis
Interventions:   Drug: MVT-5873;   Procedure: pancreatectomy or hepatectomy
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 21, 2019 / by / in
A Personalized Medicine Study for Patients With Advanced Cancer of the Breast, Prostate, Pancreas or Those With Refractory Acute Myelogenous Leukemia

Conditions:   Breast Cancer;   Prostate Cancer;   Pancreatic Cancer;   Acute Myelogenous Leukemia
Interventions:   Procedure: Biopsy;   Drug: ABIRATERONE;   Drug: ENZALUTAMIDE;   Drug: VENETOCLAX;   Drug: PALBOCICLIB;   Drug: All-trans Retinoic Acid;   Drug: BORTEZOMIB;   Drug: CABAZITAXEL;   Drug: OXALIPLATIN;   Drug: FLUOROURACIL;   Drug: FOLINIC ACID;   Drug: CARBOPLATIN;   Drug: PANOBINOSTAT;   Drug: VORINOSTAT;   Drug: PEMBROLIZUMAB;   Drug: BEVACIZUMAB;   Drug: IPILIMUMAB;   Drug: NIVOLUMAB;   Drug: EVEROLIMUS;   Drug: SIROLIMUS;   Drug: CELECOXIB;   Drug: OLAPARIB;   Drug: AFATINIB;   Drug: CABOZANTINIB;   Drug: SORAFENIB;   Drug: DASATINIB;   Drug: ERLOTINIB;   Drug: IDELALISIB;   Drug: IMATINIB;   Drug: LENVATINIB;   Drug: PERTUZUMAB;   Drug: PONATINIB;   Drug: RUXOLITINIB;   Drug: SUNITINIB;   Drug: TRAMETINIB;   Drug: VEMURAFENIB
Sponsors:   OHSU Knight Cancer Institute;   Oregon Health and Science University;   Prospect Creek Foundation
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 20, 2019 / by / in
Role of Sweetness in Glucose Regulation

Condition:   Obesity
Interventions:   Other: Control – Inhibition;   Other: Experimental I- Inhibition;   Other: Experimental II- Inhibition;   Other: Control- Stimulation;   Other: Experimental I- Stimulation;   Other: Experimental II- Stimulation;   Other: Sensory Evaluation
Sponsors:   University of Illinois at Urbana-Champaign;   Washington University School of Medicine
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 16, 2019 / by / in